There were 1,021 press releases posted in the last 24 hours and 432,253 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Frontier Medicines Presents New Preclinical Data on its Development Candidate, FMC-376, a Dual KRASG12C Inhibitor, at the 2023 AACR Annual Meeting

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image